Opens in a new tab

10x Genomics v Bruker Spatial Biology (CFI, 11 April 2025)

Date11 April 2025
CourtCFI
DivisionMunich (DE) Local Division
Type of actionGeneric application
Registry referenceApp_17187/2025 · ORD_17745/2025
PartiesPresident and Fellows of Harvard College

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By procedural order of 11 April 2025 (UPC_CFI_298/2023, ACT_568963/2023), the Munich Local Division (Judges Zigann, presiding, Kupecz and Pichlmaier) ordered the immediate continuation of the written procedure in the infringement action on EP 4 108 782 brought by 10x Genomics and President and Fellows of Harvard College against Bruker Spatial Biology and three other defendants. It set deadlines for replies to the submissions of 9 April 2025 (11 June, 11 July and 11 August 2025) and kept the oral hearing of 17 and 18 September 2025, despite an appeal pending before the Court of Appeal on the number of auxiliary requests.

Question

Should the division wait for the outcome of the appeal on auxiliary requests, as the Court of Appeal had suggested, now that the claimant had cut its 55 auxiliary requests down to four?

Decision

Four auxiliary requests are indisputably a reasonable number under Rule 30.1(c), which creates a new situation that the Court of Appeal’s suggestion could not have anticipated. The division weighed that reduced number, nearly two years of delay caused by stays, the agreed hearing date, its full calendar and the parties’ right to be heard within a reasonable time. According to the order, the longer proceedings have lasted, the more weight that right carries when deciding whether to continue.

Key points for practice

Provisions applied

Rules of Procedure
Rules 30.1(c) and 333
Case law cited
No UPC decision is cited.

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Written procedure (UPC), Court fees and costs (UPC).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Generic application
Outcome (Dhenne Avocats summary)
La procédure écrite reprend immédiatement, avec de nouveaux délais, et l'audience de septembre 2025 est maintenue, quatre requêtes subsidiaires étant un nombre raisonnable.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 4 108 782
Compositions and methods for analyte detection
recorded proprietor: Harvard University
Mentioned in the analysis (role not qualified)
Also mentioned in 18 other decision(s): NanoString Technologies v 10x Genomics (CoA, 11 March 2024) · 10x Genomics v NanoString (CFI, 19 September 2023) · 10x Genomics v Vizgen (CoA, 11 March 2025) · 10x Genomics v Vizgen (CoA, 5 March 2025) · 10x Genomics v Vizgen (CFI, 20 December 2024) · NanoString Technologies v 10x Genomics (CoA, 10 December 2024) · 10x Genomics v Vizgen (CFI, 1 November 2024) · 10x Genomics v Vizgen (CFI, ORD_49363/2024, 24 October 2024)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.